Home » Topics » Briefs » Other news to note

Other news to note
RSS

InNexus Biotechnology and Xeris to develop subcutaneous delivery of DXL antibodies

Dec. 16, 2009

Qiagen closes acquisition of SABiosciences

Dec. 15, 2009

Kowa Pharmaceuticals divests diclofenac products Cambia and PRO-571

Dec. 15, 2009

Alcon to acquire Optonol

Dec. 15, 2009

Cubist Pharmaceuticals to acquire Calixa Therapeutics

Dec. 14, 2009

Arpida completes merger with Evolva

Dec. 14, 2009

MediGene presents update on clinical development of EndoTAG-1 and RhuDex

Dec. 14, 2009

NanoPacific Holdings acquires license from UCLA for supramolecular nanoparticles

Dec. 14, 2009

Dow Chemical forms independent company Pfenex to develop recombinant proteins

Dec. 10, 2009

Stockholders approve Anesiva merger with Arcion Therapeutics

Dec. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...